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Endotoxin provocation of experimental renal cystic disease. Germ free
rats provide a unique model in which to assess biological response to
environment. In 48 germ—free male, Sprague—Dawley rats we examined
the consequences of oral exposure to nordihydroguaiaretic acid
(NDGA), a nephrotoxin; to Staphylococcus epidermidis and bacillus
species, non-endotoxin--containing bacteria; to Escherichia coli and
Proteus mirabilis, endotoxin—containing bacteria; and injected E. co/i
endotoxin on peripheral leukocyte counts and renal morphology. Mor-
phological changes were evaluated by light microscopy and scored
blindly on a 0 to 4+ scale for 15 parameters of renal structure. Means
of these renal 'pathology scores" correlated with counts of polymor-
phonuclear leukocytes and lymphocytes in the peripheral blood. The
highest counts and scores were found in rats given NDGA and exposed
to endotoxin, either by injection or by oral feeding of endotox-
in—containing bacteria. Counts and scores were lower in the absence of
endotoxin and with non-endotoxin—containing bacteria, given alone or
in combination with either NDGA or endotoxin. Results exclude
bacterial colonization and intrarenal accumulation of NDGA as causes
of nephropathy. They indicate that endotoxin and NDGA act synergis-
tically to provoke renal damage in the germ free NDGA-fed rat and
suggest that leukocytes are involved in the process.
Some giant ("cystic") nephrons, tubular epithelial prolifera-
tion, interstitial fibrosis, and inflammatory infiltrates are mor-
phologic1 characteristics of several forms of drug—induced
nephropathy in rodents [1—6]. The evolution of these lesions is
dose and time dependent. We used one model, NDGA-induced
disease, to show that the rate at which nephropathy develops
can be modified by environmental manipulation [7]. Justifica-
tion for the study related to its potential in identifying thera-
peutic approaches to human renal cystic disease (RCD). To the
extent that environment may influence the expression of RCD
in man, environmental manipulation could serve as a basis for
therapy.
In rats that were initially germ free but later deconditioned
(colonized by bacteria), we noted that nephropathy developed
within days to a degree that required weeks when conventional
animals were used [7, 8]. Aerobic and anaerobic cultures were
negative in 50% of cystic kidneys. No difference was noted in
patterns of intestinal microflora between animals with and
without renal lesions. Based on these findings, we excluded
secondary infection of cystic kidneys and colonization by a
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specific micro-organism as provocateurs of accelerated nephrop-
athy [7].
We now have examined the model in greater detail. Here we
describe experiments in which selective bacterial contamina-
tion, rather than opportunistic exposure to the ambient labora-
tory microflora, was employed to decondition germ free rats.
We contrast the effects of injected E. co/i 0113 endotoxin with
those specific, orally administered bacteria on renal morphol-
ogy and peripheral leukocyte counts. The results demonstrate
synergistic adverse effects of NDGA and endotoxin. They
suggest that polymorphonuclear leukocytes (PMNs) and lym-
phocytes (LYMPH5) participate in the evolution of nephropa-
thy.
Methods
Forty—eight six—week old, male germ free (cesarean—derived)
Sprague—Dawley rats were obtained from Charles River Labo-
ratories, Wilmington, Massachusetts, USA. Rectal swabs were
taken when the rats were received and were cultured aerobi-
cally and anaerobically using the API system (API Laborato-
ries, Plainview, New York, USA) to verify the animals' germ
free state. Animals with positive cultures were discarded. The
initial body weights of germ free rats were not obtained (to
minimize the chance of contamination) but were estimated at
150 to 170 g.
Rats were housed in individual cages within five sterilized
isolators in the Animal Resource Facility of the University of
New Mexico. Sterilized drinking water was provided ad libi-
tum. For some rats 108 colony—forming units of selected bacte-
ria were added to 500 ml of drinking water daily for the final
seven days of the study. The organisms used for mono- or
bicontamination were selected from among those found in our
earlier study [7] to be most prevalent in the feces of germ free
rats two weeks after deconditioning in the ambient environ-
ment. They included endotoxin—containing Escherichia co/i
and/or Proteus mirabilis, and non-endotoxin—containing Staph-
ylococcus epidermidis and/or bacillus species.
Feedings consisted of pelletized sterile autoclavable chow
(Wayne Rodent Blox, Continental Grain Co., Chicago, Illinois,
USA). Some animals were fed chow containing 2 to 4% by
weight NDGA (Sigma Chemical Co., St. Louis, Missouri,
USA). Chow was pelletized by Tekiad Test Diets, Madison
Wisconsin, USA. Pellet consumption for rats on NDGA was
monitored daily during the experimental period. Some rats were
injected i.p. on experimental days 14, 16, 18, and 20 with 20
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Table 1. Rat groupings by diet, and by bacteria p.o. or endotoxin i.p.
Group One Two Three Four Five Six Seven
Number of rats 5 5 5 8 9 9 7
Diet Regular Regular Regular NDGA 2% NDGA 2% NDGA 2% NDGA 2%
.
Manipulation None E. coli &/or. .P. mirabilis
.Endotoxin Staph. epi..&/or bacillus None
E. coli &/or
. . .P. mirabilis
.Endotoxin
Body weights g 386 Il 340 8 311 17 296 9 264 17 221 21 207 20
Kidney wt/l00 g body wt 0.41 0.01 0.35 0.01 0.38 0.01 0.44 0.01 0.45 0.01 0.56 0.06 0.58 0.07
Tubular cell necrosis 0.0 0.0 0,0 0.0 0.3 0.2 0.7 0.2 1.0 0.0
Tubular cell injury 0.0 0.0 0.0 0.0 0.7 0.4 1.3 0.4 1.9 0.2
Tubular atrophy 0.0 0.0 0.0 0.0 0.4 0.3 0.8 0.3 0.7 0.4
Tubular dilation 0.0 0.0 0.0 0.0 0.4 0.3 0.8 0.3 1.0 0.3
Tubular debris 0.0 0.0 0.0 0.0 0.4 0.3 0.9 0.3 0.7 0.4
Micropolyp formation 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.3 0.7 0.4
Lymphocyte infiltrates 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.4 0.2
Neutrophil infiltrates 0.0 0.0 0.0 0.0 0.3 0.2 0.7 0.3 0.7 0.4
Interstitial fibrosis 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.4 0.2
Shown are means (±sE) of final body weights, kidney/body weight ratios, and evalution scores of individual parameters of renal morphology.
nanograms E. coli 0113 endotoxin (Associates of Cape Cod,
Woods Hole, Massachusetts, USA). In a preliminary survey we
found that this dose did not produce shock or death but did
produce a febrile response within 30 minutes after i.p. injection
in five of five rats.
Rats were sacrificed on the 21st or 22nd experimental day
under i.p. sodium pentobarbital anesthesia (5 mg/lOO g body
wt). Through a midline abdominal incision, left kidneys were
removed and weighed. Right kidneys were perfused in situ with
50 ml of normal saline and 100 ml of 1% glutaraldehyde in
Tyrode's solution after exsanguination via abdominal aortic
puncture. Cecal contents were obtained at sacrifice and cul-
tured aerobically and anaerobically (API system). Blood was
transferred to EDTA tubes. Total white blood cell (WBC)
counts were performed using a Coulter Counter (Model ZB 1,
Coulter Electronics, Hialeah, Florida, USA). Differential WBC
counts were determined manually by routine methods. Sections
of renal tissue were prepared for light and electron microscopic
examination as described previously [7, 8]. Fifteen different
renal abnormalities were assessed by a blinded observer (AE)
using light microscopy and were graded on a 0 to 4+ scale (0,
absence of lesion; 1+, minimal lesion in less than 10% of
sample; 2+, moderate lesion in up to 50% of tissue; 3+,
moderate lesion in 50 to 90% of tissue; 4+, severe lesion in over
90% of tissue), Values for each rat were averaged and reported
as "pathology score."
Left kidneys from 15 endotoxin—exposed and 4 non-endotox-
in—exposed rats were selected at random, and cortical portions
and papillae were excised. These tissues were dessicated at
room temperature until weights stabilized (2 to 3 days) and then
assayed for their contents of NDGA by high performance liquid
chromatography (HPLC), using a method devised in our labo-
ratory [9].
Statistical evaluations of results included one—way analysis of
variance, Student's t-test, least squares, Neuman—Keuls test
and the Kruskal—Wallis and Mann—Whitney U (non-parametric)
tests of differences in rank order [10, 11]. A P value of less than
0.05 was considered significant.
Protocol design yielded seven groups of five to nine rats each:
Group 1) regular diet and no endotoxin exposure; Group 2)
regular diet plus feeding of endotoxin—containing bacteria;
Group 3) regular diet plus endotoxin injections; Group 4)
NDGA diet plus feeding of non-endotoxin—containing bacteria;
Group 5) NDGA diet alone; Group 6) NDGA diet plus feeding
of endotoxin—containing bacteria; Group 7) NDGA diet plus
endotoxin injections.
Results
Daily food consumption per rat ranged between 1.6 and 5.2
pellets (6.4 to 20.8 g). Over the entire experimental period,
NDGA-fed rats consumed an average of 11.8 g (6.4 to 20.2 g) of
the drug, with intakes among the groups as follows (Mean
SEM): Group 4, 11.4 0.3; Group 5, 14.5 1.2; Group 6, 10.2
1.4; Group 7, 11.0 1.5 g. Only the difference between
Groups 4 and 5 was significant (Neuman—Keuls test).
Cultures from rats that were not exposed to bacteria showed
no growth after 72 hours. Cultures from rats that were fed
bacteria grew only the proffered organisms. Cross—contamina-
tion and growth of extraneous organisms were not found.
The numbers of rats and the means of body and kidney
weights at sacrifice are shown for each group of rats in Table 1.
Nine parameters of renal morphology and their individual mean
scores also are listed (Table 1). Glomerular injury and sclerosis,
vascular injury and sclerosis, thickened basement membrane,
and hemorrhage were absent from all kidneys, were scored
"0", and are omitted from Table 1. Light microscopic appear-
ances of kidneys from NDGA-fed rats exposed or not exposed
to endotoxin are shown in Figure 1. Lesions characteristic of
injury caused by endotoxin, including fibrin deposition, capil-
lary occlusion, hyaline degeneration, and platelet aggregation,
were not seen.
Figure 2 presents mean peripheral leukocyte (PMNs and
LYMPHs) counts and pathology scores for each group. The
greatest degree of leukocytosis and the highest pathology
scores were recorded among those animals fed NDGA and
exposed to endotoxin (Groups 6 and 7). Changes in body
weights, kidney—to—body weight ratios and leukocyte counts
were less pronounced among rats exposed only to endotoxin
(Groups 2 and 3), fed NDGA but deconditioned with non-
endotoxin—containing micro-organisms (Group 4), or fed
NDGA but neither deconditioned nor injected (Group 5) (Table
1; Fig. 2). When data from control, non-endotoxin—exposed,
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Fig. 1. A Light micrograph of renal cortex with proximal tubules (P) and a glomerulus (G)from a germfree rat that received NDGA only (Group
5). No changes are seen in tubules or interstitium (x 40). B Light micrograph of renal cortex from germfree rat that received both NDGA and
endotoxin injection (Group 7). Note cysts (C). The interstitium is expanded by infiltrating PMNs (arrows) and an increased number of interstitial
cells (x 40).
and endotoxin—exposed rats were combined, the differences
among groups remained significant (Table 2).
Renal pathology scores correlated significantly with the fol-
lowing parameters: final body weights (r —0.33, P < 0.02);
peripheral leukocyte counts (vs. PMNS, r = 0.57, P < 0.001;
vs. LYMPHs, r = 0.56, P < 0.001); kidney weights/l00 g body
wt (r = 0.69, P < 0.001); and, among those kidneys assayed,
NDGA content (cortex, r = 0.71, P < 0.03; papilla, r = 0.83, P
= 0,008). Significant correlations also were found between
leukocytes in the circulation and in the renal parenchyma (for
PMNs, r = 0.56; for LYMPHs, r = 0.48) and between circu-
lating leukocytes and the estimated severity of renal tubular
dilation (for PMNs, r = 0.56; for LYMPHs r 0.49) (P for all
<0.001).
Tissue assays revealed significant differences between re-
gions in NDGA content (Fig. 3). Cortical contents averaged (±
SE) 0.434 mg NDGA/g dry tissue weight, while papillary con-
tents averaged 4.442 1.010 (P < 0.001 by Student's t-test).
Within regions, however, no significant effect of endotoxin on
tissue NDGA content was demonstrated (Fig. 3).
Discussion
The germ free or axenic animal is an ideal subject in which to
assess host—pathogen interactions and specific drugs effects. It
is free of opportunistic micro-organisms that may complicate
results [121. Because it lacks intestinal bacteria, it is better able
to survive uremia after bilateral nephrectomy [13]. Its kidneys
are slower to show senescence [121 and to develop focal
glomerular sclerosis [141. They are susceptible to the adverse
renal effects of increased dietary protein [12]. Their NADP-
dependent dehydrogenase activity is equivalent to that found in
kidneys of conventional rats [15].
NDGA is a nephrotoxic lignan present in the leaves of Larrea
divaricata, the common creosote bush or chapparal [16—18]. It
is used in biological studies to inhibit the lipoxygenase and
cyclooxygenase pathways of arachidonic acid metabolism [19]
and to induce RCD [2, 7, 8]. It once was considered for use as
a food preservative because of its antioxidant properties [20]
and as a candidate drug in the treatment of human cancer [211.
Its nephrotoxicity was attributed to effects of its metabolites
(quinones) when chromatography failed to demonstrate its
presence in the kidneys of NDGA-fed rats [2, 20].
The changes induced in rat kidneys by NDGA have been
described in detail [2, 7, 8, 20] and include tubular cell injury;
local and focal dilation of tubules (cyst formation); tubular cell
necrosis; focal proliferation of tubular epithelium; focal infiltra-
tion of interstitium and tubular lumens by PMNs, LYMPHs,
macrophages and round cells; and interstitial fibrosis. These
changes are absent from the kidneys of germ free NDGA-fed
rats ([7] and Group 5), indicating that dietary NDGA alone
cannot provoke them.
When results from our earlier study did not implicate either a
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. 
a
 C, 
332 Gardner, Jr. et a!
*
*1 I -
Rat group (by number)
Fig. 2. Bar graphs of mean (± SE) circulating polymorphonuclear
leukocytes and lymphocyte counts, mean (± SE) renalpathology scores
for each of the seven groups of rats. Variance among groups was
significant for each parameter (for PMNs and LYMPHs: Kruskall—Wal-
lis, P < 0.001; for pathology scores: ANOVA, P < 0.001). Asterisk
indicates significant difference from preceding mgan value (for PMNs
and LYMPHs: Mann—Whitney, P < 0.01; for pathology scores: Stu-
dent's t-test, P < 0.007). For key to experimental groups see footnote
to Table 2.
particular colonizing microbe or renal infection as a variable
contributing to nephropathy [71, endotoxin was considered.
Endotoxins are lipopolysaccharide—protein complexes found in
the cell walls of gram—negative organisms [22]. They cause a
complex array of reactions and interactions in the biological
host, including peripheral leukocytosis, complement activation,
reduced glomerular filtration and microthrombosis in glomeru-
lar capillaries, and, in vitro, damage to renal tubular epithelium
[23—27]. These effects, among others, usually have been defined
in acute (hours in duration) studies in conventional animals,
using greater doses of endotoxin (such as, 0.65 mg/hr i.v. for
two hours [26]) than were used here.
In our study rats exposed to endotoxin and/or NDGA had
lower body weights (Table I), despite statistically similar food
and drug intakes among all groups but two. Differences in mean
final weights might reflect chance selection of larger animals as
controls, undocumented endotoxin or NDGA-induced reduc-
tions in caloric utilization, or development of azotemia. Insuf-
ficient data were obtained to identify the specific cause. Others
who have studied NDGA-fed rats have attributed their retarded
weight gain without reduced food intake to renal or pulmonary
disease. Renal disease developed in our animals [20].
As a candidate provocateur for RCD, endotoxin is attractive
for miscellaneous reasons. It stimulates arachidonic acid me-
tabolism in obstructed kidneys [28], and we have postulated
that partial obstruction exists in cystic kidneys [29]. It exacer-
bates the renal lesions induced by lead, glycerol, and some
antibiotics [30—32], agents that, like NDGA, injure tubular cells.
It is widely distributed in nature [22]. Dialysis patients may be
exposed to it [33]. Antagonists to its effects are available for
study [34]. When used alone here, neither endotoxin nor NDGA
produced changes in renal morphology. Each was associated
with a two— to fourfold increase in circulating leukocyte counts
(Table 1 and Fig. 2).
The most severe changes in renal morphology and circulating
leukocyte counts (five— to tenfold increases) were found in rats
exposed to both NDGA and endotoxin (Groups 6 and 7).
Changes were greater with intraperitoneal (Group 7) than with
oral (Group 6) endotoxin (Fig. 2), perhaps reflecting differences
in overall dose or the degree or acuity of change in blood levels
of endotoxin between the injected and the bacteria—fed animals.
Our protocol was not designed to discriminate among these
alternatives.
The mechanism of the synergistic effect observed between
NDGA and endotoxin on counts and morphology is conjectural.
Two possible explanations are unlikely. First, the absence of
fibrin deposition, capillary occlusion, hyaline degeneration, and
platelet aggregation from kidneys indicates that endotoxin's
effect was not mediated through development of these lesions.
Second, endotoxin did not alter kidney NDGA content (Fig. 3),
indicating that it did not enhance nephropathy by increasing the
jntrarenal accumulation of NDGA.
A third, more likely explanation relates to an effect mediated
through white blood cells. The frequent finding of leukocytes in
apposition to dilated nephrons and cysts ([7] and Fig. 1) led us
to query the relationship between leukocytosis and cystic
nephropathy. We examined correlations between the numbers
of circulating leukocytes and renal pathology scores, between
leukocytes in the circulation and in the kidneys, and between
leukocytes and the degree of tubular dilation. Direct and
statistically significant correlations were found.
Other studies have demonstrated the capability of leukocytes
to damage renal tissue. PMNs from acute pyelonephritic exu-
dates in rats lyse syngeneic renal epithelial cells in vitro,
independent of antibody or lectins [35]. Lymphocytes partici-
pate in the interstitial nephritic response [36J. Cytotoxic oxygen
radicals are released at sites of inflammation [37—40]. Further-
more, in vitro, NDGA inhibits catalase and peroxidase activity
[41], two enzymes known to protect cellular machinery from
superoxide and other reduced forms of oxygen [42]. We sug-
gest, therefore, that endotoxin in the model enhanced release of
leukocytes into the circulation and that these cells accumulated
in the NDGA-damaged kidney, where they contributed to
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Table 2. Combined data based on diet type and presence or absence of endotoxin exposure
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Group(s) Diet
Endotoxin
exposure
Number
of rats
Kidney wts
per 100 g
body wt
Mean (± SE)
circulating
PMNs
Mean (± SE)
circulating
LYMPHs
Mean (± SE)
pathology
score
One Regular No 5 0.41 0.01 268 15 153 III 0
Two + Three Regular Yes 10 0.37 0.Ola 1219 175 3320 321 0
Four + Five NDGA No 17 0.44 0.OIa 963 120 2932 3l6 0.3 0.1
Six + Seven NDGA Yes 16 0.57 000b 324! 848b 7680 1815b 1.3 02b
Significantly different from controls, Group One; P < 0.05, Student's t-testb Significantly different from all preceeding values; P < 0.05, Student's I-test
44iI1II
1 3 5 7 9 11 13 15 17 19 21 23 25
Tissue sample number
Fig. 3. NDGA contents, ranked in ascending order from Ito 27, of 15
cortical () and 12 papillary (U) tissue samples from kidneys exposed
(+) or not exposed to endotoxin. Of those from endotoxin-exposed rats,
sample nos. 1, 10, 12, 15, 25, and 27 came from rats fed endotoxin-
containing bacteria; samples nos. 2,5, 7, 8, 11, 13, 16, 17, 23, 24, and
26 came from rats injected with endotoxin.
cystic nephropathy through release of cytotoxic oxygen radi-
cals and altered arachidonic acid metabolism.
A fourth possibility, that endotoxin enhanced the intra-
renal formation of nephrotoxic NDGA metabolites (quinones)
through enzyme induction or heightened inflammatory response
[391, could not be excluded by our results. During HPLC
analyses of kidneys for NDGA contents, we noted products
with retention times similar to those of compounds produced in
vitro when NDGA is oxidized with horseradish peroxidase (Fig.
4). As defined by areas beneath HPLC peaks, these compounds
were present in significantly greater amounts (P < 0.04) and as
compound—to—NDGA ratios (P <0.02) in kidneys exposed to
endotoxin (Mann—Whitney U test). Conceivably one or both are
quinone derivatives, the nephrotoxic oxidation products of
NDGA that were identified by Grice et al [2, 201.
Whether events in the model can be related to the expression
of human RCD is speculative. No nephrotoxic cystogen has
been identified and no leukocyte—mediated damage has been
confirmed in human RCD. However, the morphology of ac-
quired RCD, with its interstitial infiltrates and neoplastic epi-
thelial cells [43], resembles that of the model. Serum from
patients with chronic renal failure enhances the oxidative
metabolism of PMNs [44]. In autosomal dominant polycystic
kidney disease (ADPKD), the counts of circulating PMNs are
significantly higher among persons with known than among
persons with suspected or absent ADPKD [45]. While bacteri-
uria and pyuria are common in ADPKD, cyst infection is rare
[40]. Nonetheless, we have found peroxidase activity in 6 of 10
sterile cysts from a polycystic kidney and leukotriene B4 in four
NDGA STD
Fig. 4. HPLC profiles of NDGA / 9] and suspected metabolites. NDGA
STD—NDGA standard (NDGA in absolute ethanol, 1 mg/mI); NDGA
HRP—NDGA in ethanol after addition of horseradish peroxidase;
KIDNEY ANALYSIS—homogenate in ethanol of renal tissue from
NDGA-fed, endotoxin injected rat. NDGA peak (A and heavy arrow)
appeared at 3.89 to 3.95 minutes. Similar retention times for compounds
at 2.8 (B) and 2.0 (C) minutes in peroxidase—treated solution of NDGA
and in ethanol eluate of tissue suggest but do not prove presence of
oxidation products of NDGA in kidney homogenate.
of four sterile cysts from a kidney with acquired disease
(personal observation). These anecdotal observations are com-
patible with the possibility that leukocyte—mediated damage,
unrelated to ongoing secondary infection, hastens expression of
RCD in man. The extent to which observations in the
deconditioned germ free rat fed NDGA exemplify a more
generic interrelationship among nephrotoxins, leukocytes,
endotoxins, and RCD remains a question for future study.
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